caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1346211380

Diana LakeMD

PRACTICEMSKCC SURGERY GROUPSee all providers at this practice →
Medical OncologyNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Diana Lake's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 4 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Daphna Gelblum
Radiation Oncology · Commack, NY
1286
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES2103,694
Lizza Lebron-Zapata
Diagnostic Radiology · New York, NY
18118
Quest Diagnostics Incorporated
Clinical Laboratory · Clifton, NJ
1367
Daphna Gelblum
Radiation Oncology · Commack, NY
12396
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
229
Unique beneficiaries
—
Total services
474
Distinct HCPCS
4
Medicare payment
$43K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 506 Medical Oncology providers in NY — above median (cohort median 458).
QUALITY · MIPS · 2024
Final MIPS score
80.4
Quality
74.7
Cost
69.1
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.23%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
643
Beneficiaries
—
Total drug cost
$1.2M
Distinct drugs
9
Brand share
15.7%
Top prescribed drugs
Letrozole259 claims
Tamoxifen Citrate101 claims
Exemestane79 claims
Anastrozole69 claims
Palbociclib45 claims